Trial Profile
A Retrospective, Longitudinal, Pre–Post Study Comparing Health Care Resource Utilization before and after Perampanel Initiation for the Treatment of Epilepsy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Jun 2021
Price :
$35
*
At a glance
- Drugs Perampanel (Primary) ; Antiepileptic drugs
- Indications Epilepsy
- Focus Therapeutic Use
- 01 May 2021 Results published in the Epilepsy and Behavior
- 09 Dec 2019 Results published in an Eisai Inc Media Release
- 09 Dec 2019 According to an Eisai Inc media release, data from this study were presented at the 2019 American Epilepsy Society Annual Meeting.